«

»

May 07

A new study has shown that an HDL mimetic used in the treatment of patients with ACS could not reduce the burden of atherosclerotic disease

A new study has shown that an HDL mimetic used in the treatment of patients with ACS could not reduce the burden of atherosclerotic disease. The findings are published online in the European Heart Journal.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>